Coronavirus Notebook: Regeneron, HHS To Develop Antibody

China Domestics Step Up R&D Efforts

 
• By Brian Yang

Wuhan Institute of Pathology files patent over new use of Gilead's remdesivir and Regeneron expands collaboration with HHS to include 2019-nCoV.  

LARGELY EMPTY STREETS IN BEIJING AS HOLIDAY PROLONGED FOR ANOTHER WEEK
STREETS LARGELY EMPTY AS BEIJING, 22 PROVINCES EXTEND HOLIDAY • Source: Brian Yang

More from China

More from Focus On Asia